Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
about
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesRemoval of silver nanoparticles by mussel-inspired Fe3O4@ polydopamine core-shell microspheres and its use as efficient catalyst for methylene blue reduction.A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation.From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.
P2860
Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
@en
type
label
Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
@en
prefLabel
Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
@en
P2093
P2860
P356
P1433
P1476
Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.
@en
P2093
Andrea C LeBlanc
Bénédicte Foveau
Gyanesh Sharma
Prateep Pakavathkumar
Vikas Kaushal
P2860
P2888
P356
10.1038/SREP13730
P407
P577
2015-09-24T00:00:00Z
P5875
P6179
1003610513